SCHEMBL6665852

SCHEMBL6665852

Cc1ccc2ncnc(Nc3ccc([N+](=O)[O-])cc3)c2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.70
EGFR P00533 5/20 0.69
ABCG2 Q9UNQ0 2/20 0.67
HTT P42858 5/20 0.66
MAPT P10636 4/20 0.66
ALDH1A1 P00352 3/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
KDM4E B2RXH2 2/20 0.65
MAPK1 P28482 2/20 0.65
NCOA1 Q15788 2/20 0.65
NCOA3 Q9Y6Q9 2/20 0.65
GAA P10253 1/20 0.65
SMN1; SMN2 Q16637 2/20 0.62
LMNA P02545 1/20 0.62
EIF2AK2 P19525 1/20 0.61
KMT2A Q03164 2/20 0.59
JAK2 O60674 1/20 0.59
MITF O75030 1/20 0.59
PAX8 Q06710 1/20 0.59
MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30827902 0.85 ALK (0.70) ALKEGFRABCG2HTTMAPT
SCHEMBL29199908 0.85 ALK (0.70) ALKEGFRABCG2HTTMAPT
SCHEMBL8871504 0.84 EGFR (0.76) ALKEGFRABCG2HTTMAPT
SCHEMBL4587672 0.83 ALK (0.79) ALKEGFRABCG2HTTMAPT
SCHEMBL3244626 0.82 ALK (0.77) ALKEGFRABCG2HTTMAPT
SCHEMBL1192454 0.82 EGFR (1.00) ALKEGFRABCG2HTTMAPT
SCHEMBL29116258 0.81 ABCG2 (0.74) ALKEGFRABCG2HTTMAPT
SCHEMBL5564480 0.81 MAPK1 (0.76) ALKEGFRHTTMAPTALDH1A1
SCHEMBL6663823 0.80 ALK (0.74) ALKEGFRABCG2HTTMAPT
SCHEMBL5473767 0.80 ABCG2 (1.00) ALKEGFRABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed